Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Oct 03, 2024 | Oct 04, 2024 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Sell | Bioxcel Therapeutics, Inc. | BTAI | $0.55 | $3,450 | -24.81% |
Sep 16, 2024 | Sep 17, 2024 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Sell | Bioxcel Therapeutics, Inc. | BTAI | $0.69 | $149 | -5.06% |
Jun 17, 2024 | Jun 19, 2024 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Sell | Bioxcel Therapeutics, Inc. | BTAI | $1.26 | $308 | -6.52% |
Apr 04, 2024 | Apr 08, 2024 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Sell | Bioxcel Therapeutics, Inc. | BTAI | $2.64 | $2,656 | -25.20% |
Mar 05, 2019 | Mar 06, 2019 | Wiley Matthew T. Chief Commercial Officer | Buy | Foamix Pharmaceuticals Ltd. | FOMX | $3.76 | $50,534 | +17.48% |